Legend Biotech Corporation
LEGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $627,241 | $285,143 | $117,005 | $68,826 |
| % Growth | 120% | 143.7% | 70% | – |
| Cost of Goods Sold | $234,581 | $144,214 | $65,363 | $0 |
| Gross Profit | $392,660 | $140,929 | $51,642 | $68,826 |
| % Margin | 62.6% | 49.4% | 44.1% | 100% |
| R&D Expenses | $413,544 | $382,218 | $335,648 | $313,346 |
| G&A Expenses | $136,783 | $106,769 | $80,631 | $46,961 |
| SG&A Expenses | $284,264 | $200,927 | $174,048 | $149,503 |
| Sales & Mktg Exp. | $147,481 | $94,158 | $93,417 | $102,542 |
| Other Operating Expenses | -$1,905 | -$2,731 | -$2,434 | -$1,736 |
| Operating Expenses | $695,903 | $580,414 | $507,262 | $461,113 |
| Operating Income | -$303,243 | -$439,485 | -$455,620 | -$392,287 |
| % Margin | -48.3% | -154.1% | -389.4% | -570% |
| Other Income/Exp. Net | $145,110 | -$80,633 | $9,896 | -$14,909 |
| Pre-Tax Income | -$158,133 | -$520,118 | -$445,724 | -$407,196 |
| Tax Expense | $18,893 | -$1,864 | $625 | -$3,614 |
| Net Income | -$177,026 | -$518,254 | -$446,349 | -$403,582 |
| % Margin | -28.2% | -181.8% | -381.5% | -586.4% |
| EPS | -1.94 | -5.88 | -5.62 | -5.48 |
| % Growth | 67% | -4.6% | -2.6% | – |
| EPS Diluted | -1.94 | -5.88 | -5.62 | -5.48 |
| Weighted Avg Shares Out | 91,426 | 88,041 | 79,521 | 70,426 |
| Weighted Avg Shares Out Dil | 91,426 | 88,041 | 79,521 | 70,426 |
| Supplemental Information | – | – | – | – |
| Interest Income | $61,204 | $54,487 | $8,182 | $971 |
| Interest Expense | $21,615 | $21,794 | $10,796 | $900 |
| Depreciation & Amortization | $23,359 | $20,451 | $18,392 | $13,917 |
| EBITDA | -$113,159 | -$477,873 | -$416,536 | -$392,379 |
| % Margin | -18% | -167.6% | -356% | -570.1% |